FYN anticorps (AA 154-270) (HRP)

N° du produit ABIN6063113

Détail du produit anti-FYN anticorps (HRP)

Antigène: FYN (FYN Oncogene Related To SRC, FGR, YES (FYN))

Épitope: AA 154-270

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FYN est conjugé à/à la HRP

Application: ELISA

Purification: Protein G

Immunogène: Recombinant human Tyrosine-protein kinase Fyn protein (154-270AA).

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 0.01 M PBS,  pH 7.4, 0.03 % Proclin-300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Aliquot and store at -20 °C or -80 °C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.

Détails sur FYN

Antigène: FYN (FYN Oncogene Related To SRC, FGR, YES (FYN))

Autre désignation: FYN (FYN Produits)

Synonymes: anticorps im:6908851, anticorps si:dkey-119m7.5, anticorps zgc:109996, anticorps c-fyn, anticorps cfyn-a, anticorps SLK, anticorps SYN, anticorps p59-FYN, anticorps PKC, anticorps fyn, anticorps zgc:86720, anticorps AI448320, anticorps AW552119, anticorps FYN proto-oncogene, Src family tyrosine kinase, anticorps FYN proto-oncogene, Src family tyrosine kinase S homeolog, anticorps FYN proto-oncogene, Src family tyrosine kinase b, anticorps FYN proto-oncogene, Src family tyrosine kinase L homeolog, anticorps FYN proto-oncogene, Src family tyrosine kinase a, anticorps Fyn proto-oncogene, anticorps FYN, anticorps fyn.S, anticorps fynb, anticorps fyn.L, anticorps Fyn, anticorps fyna

ID gène: 2534

UniProt: P06241

Pathways: Signalistation JAK/STAT, TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Feeding Behaviour, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Activated T Cell Proliferation, Thromboxane A2 Receptor Signaling